Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.
about
HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.Further characterization of a highly attenuated Yersinia pestis CO92 mutant deleted for the genes encoding Braun lipoprotein and plasminogen activator protease in murine alveolar and primary human macrophages.Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Escherichia coli Braun Lipoprotein (BLP) exhibits endotoxemia - like pathology in Swiss albino mice.Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants.New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic Plague.Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunity.Escherichia coli lipoprotein binds human plasminogen via an intramolecular domain.Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis.Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.
P2860
Q34633478-684C84D2-21FA-45A7-81BD-648FBAA74F9DQ35186608-D86E6A4C-753C-4650-BB0C-42C962B865B1Q35187610-5E270AFF-A336-4B2F-B3CE-F43B18E1DA84Q35439470-7A03FB4D-7049-40B7-B007-7F8E1723315DQ36316792-061F0F5A-4490-4385-AF81-05F29059CB99Q37067254-D90C9B2E-CD1A-42C9-B022-9AE55C84305DQ37307082-CF5AD4DD-6482-4F78-BCA2-7095FFBF865EQ37405767-F871D696-44B7-4FF7-824D-13A925CC1A95Q37503760-4F153CC8-A0CB-4EF8-B4F1-874EFC64A7DFQ38612236-55478558-DF61-494C-955B-502429065394Q40937719-CCDCD184-693A-45BA-A3B7-314EABBBC82AQ46463260-989D8A40-6700-4211-A26A-41DBA71DC660Q47293934-61EC1732-AFA5-4404-A8B0-4F1BE72EDC68Q47721065-0CEA1763-2F9A-4C77-BD7C-E4CB630C7A1D
P2860
Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Deletion of Braun lipoprotein ...... bubonic and pneumonic plague.
@ast
Deletion of Braun lipoprotein ...... bubonic and pneumonic plague.
@en
type
label
Deletion of Braun lipoprotein ...... bubonic and pneumonic plague.
@ast
Deletion of Braun lipoprotein ...... bubonic and pneumonic plague.
@en
prefLabel
Deletion of Braun lipoprotein ...... bubonic and pneumonic plague.
@ast
Deletion of Braun lipoprotein ...... bubonic and pneumonic plague.
@en
P2093
P2860
P356
P1476
Deletion of Braun lipoprotein ...... bubonic and pneumonic plague.
@en
P2093
Anthony Cao
Ashok K Chopra
Bethany L Tiner
Christina J van Lier
Elena V Kozlova
Michelle L Kirtley
Tatiana E Erova
Vsevolod L Popov
Wallace B Baze
P2860
P304
P356
10.1128/IAI.01595-13
P407
P50
P577
2014-03-31T00:00:00Z